1. IndiaInfoline
  2. Search
Displaying Results for "biocon"
Showing Results 1 - 19 of 769

Biocon Limited - BUY

India Infoline Research Team  | Mumbai October 07, 2014 15:47 IST

Biocon is looking to move up the value chain from APIs to finished dosages and has forayed in to the US generics market with its first set of ANDAs filings.

Biocon to hold board meeting

capital market  | Mumbai October 01, 2014 12:38 IST

On 21 October 2014

Biocon to hold board meeting

capital market  | Mumbai October 01, 2014 00:00 IST

Biocon will hold a meeting of the Board of Directors of the Company on 21 October 2014, to approve and take on record the unaudited financial results of the Company for the quarter and half year ended 30 September 2014 (Q2).

Biocon stock up 2%

India Infoline News Service  | Mumbai September 19, 2014 09:53 IST

The stock has hit a high of Rs514 and a low of Rs506.

Biocon gains after selling 10% stake in Syngene

capital market  | Mumbai September 19, 2014 09:23 IST

Biocon rose 2.31% to Rs 511.50 at 9:25 IST on BSE after the company said it sold a 10% stake in its research services arm, Syngene International, to Silver Leaf Oak (Mauritius) for Rs 380 crore.

Biocon Limited - Press Release

capital market  | Mumbai September 19, 2014 00:00 IST

Biocon Limited has informed the Exchange regarding a press release dated Sept. 18, 2014 titled Silver Leaf Oak acquires 10% stake in Syngene International, Biocon's Research Services Subsidiary.

Biocon announces buying of stake by Silver Leaf Oak (Mauritius) in its subsidiary

capital market  | Mumbai September 18, 2014 18:05 IST

Silver Leaf to acquire 10% stake in Syngene International

Biocon announces buying of stake by Silver Leaf Oak (Mauritius) in its subsidiary

capital market  | Mumbai September 18, 2014 00:00 IST

Biocon announced that Silver Leaf Oak (Mauritius), an investment vehicle advised by India Value Fund Advisors (IVFA) has agreed to acquire a minority 10% stake in Syngene International, Biocon's Research Services subsidiary. <p>Silver Leaf will acquire the stake from Biocon Research, a wholly owned subsidiary of Biocon at a valuation of Rs 3800 crore. Post completion of this transaction, Biocon and BRL will jointly hold 85.54% stake in Syngene.

Biocon slips on profit booking

capital market  | Mumbai September 11, 2014 13:50 IST

Biocon fell 1.87% to Rs 494.60 at 13:50 IST on BSE on profit booking after the stock rose 8.45% in the preceding eight trading sessions to Rs 504 on 10 September 2014, from a recent low of Rs 464.75 on 28 August 2014.

Biocon Limited - Updates

capital market  | Mumbai September 10, 2014 00:00 IST

Biocon Limited has informed the Exchange regarding purchase of shares in Syngene International Limited by Biocon Research Limited.

Biocon arm enters into agreement with GE Equity

India Infoline News Service  | Mumbai September 09, 2014 18:05 IST

GE Capital had a 7.69% stake in Syngene.

Biocon's subsidiary to acquire 7.69% stake in Syngene International

capital market  | Mumbai September 09, 2014 17:10 IST

For Rs 215.38 crore

Biocon's subsidiary to acquire 7.69% stake in Syngene International

capital market  | Mumbai September 09, 2014 00:00 IST

Biocon announced regarding a matter taken up at the meeting of the Board of Biocon Research, a wholly owned subsidiary of the Company held on 09 September 2014.<p>Biocon Research has entered into an agreement with GE Equity International Mauritius, a subsidiary of GE Capital Corporation (GE Capital), to purchase the latter's investment in Biocon's research services subsidiary, Syngene International (Syngene) for an agreed consideration of Rs. 215.38 crore. GE Capital had a 7.69% stake in Syngene.

Biocon Foundation Receives Asia Best CSR Practices Award 2014 for Cervical Cancer Screening Program

Business Wire  | August 12, 2014 19:54 IST

Biocon Foundation Receives Asia Best CSR Practices Award 2014 for Cervical Cancer Screening Program

Biocon to mark decade of Excellence in affordable Insulin Therapy

India Infoline News Service  | Mumbai August 11, 2014 10:39 IST

Biocon kicked off a series of patient outreach programs which it has been touching the lives of lakhs of diabetic patient.

Biocon Limited - Press Release

capital market  | Mumbai August 11, 2014 00:00 IST

Biocon Limited has informed the Exchange, vide letter dated August 11, 2014 regarding a press release dated August 10, 2014 titled Biocon to Mark a Decade of Excellence in Affordable Insulin Therapy.

Biocon Limited - Discl. under SEBI Insider Trading and Takeover Regulation

capital market  | Mumbai August 04, 2014 00:00 IST

Biocon Limited has submitted to the Exchange vide letter dated July 30, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011along with Disclosure under Regulation 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Biocon announces dividend payment date

capital market  | Mumbai July 30, 2014 12:02 IST

Dividend payment date is 31 July 2014

Biocon Limited - Date of payment of dividend

capital market  | Mumbai July 30, 2014 00:00 IST

Biocon Limited has informed the Exchange that the dividend of Rs. 5/- per equity share approved by the members of the Company at the Annual General Meeting held on July 25, 2014 will be paid out on July 31, 2014.

Back to Top

 

 
 
 
Recent Reports
News